FDA-Drug2024-12-18Class II
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
Mylan Institutional, Inc.
Hazard
Subpotent and Superpotent Drug
Sold states
Nationwide in the USA.
Affected count
205 cartons
Manufactured in
1718 Northrock Ct, Rockford, IL, United States
Products
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0136-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief